Serotonin Syndrome in the Perioperative Setting #MMPMID30008467
Smischney NJ; Pollard EM; Nookala AU; Olatoye OO
Am J Case Rep 2018[]; 19 (ä): 833-5 PMID30008467show ga
Patient: Male, 70Final Diagnosis: Serotonin syndromeSymptoms: Myoclonus ? rigidityMedication: ?Clinical Procedure: Photoseletive vaporization of prostateSpecialty: AnasthesiologyObjective:: Mistake in diagnosis Background:: Serotonin syndrome is a life-threatening condition that can lead to neurologic complications and is associated with the use of serotonergic medications. As the use of antidepressant medications has increased, the incidence of perioperative serotonin syndrome has transitioned from a rare diagnosis to one that should be considered as a differential diagnosis for any patient displaying signs of neuroexcitation. Case Report:: A 70-year-old man (ASA 2) with a history of vestibular migraines (treated with venlafaxine), gastroesophageal reflux disease, and benign prostatic hyperplasia presented to our institution for photoselective vaporization of the prostate. Upon review of prior anesthetic records, his medical chart was found to list a propofol allergy. In discussion with the patient, he stated the reaction was rigidity. The anesthesiologist and patient agreed this was not an allergy. Thus, the patient was induced with propofol and given ketamine and fentanyl boluses throughout the procedure. During emergence, the patient exhibited myoclonic jerks in the upper and lower extremities. He was given intravenous meperidine for postoperative shivering; minutes after administration, the myoclonic jerks and rigidity worsened. The anesthesia team raised concern about serotonin syndrome. Intravenous midazolam improved the patient?s myoclonic jerks and rigidity. Conclusions:: Patients with a history of rigidity/movement disorders during the perioperative period may have experienced serotonin toxicity. It is possible, as in our case, for this history to have been labelled as an allergy to a perioperative medication. Clinicians should remain vigilant for patients at risk of developing serotonin syndrome, such as those taking outpatient medications that increase neuronal serotonin.
free
free
free
Am+J+Case+Rep 2018 ; 19 (ä): 833-5
